Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Norgine's Moviprep licensed for Canada

This article was originally published in Scrip

Executive Summary

Norginehas concluded its second licensing agreement in the past three months for its bowel cleansing product Moviprep. It has licensed Moviprep to Medical Futures for marketing in Canada, in return for an undisclosed upfront payment and royalties on sales. Medical Futures, a privately held Canadian company set up in 2000, already markets a range of gastrointestinal products, including the herbal extract Iberogast for non-ulcer dyspepsia and irritable bowel syndrome, and the probiotic treatment for diarrhoea, Florastar. In October, Norgine licensed Moviprep to Ajinomoto (Scrip Online, October 15th, 2008).



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts